Dudediligence.

GeneDx Holdings Corp

WGSNASDAQ · Services-Health Services
Write an idea

Fundamentals

Oldest to newest
Revenue, by quarter
$76.9MSep ’24$95.6MDec ’24$87.1MMar ’25$102.7MJun ’25$116.7MSep ’25$121.0MDec ’25$102.3MMar ’26$114.4MJun ’26
Net income, by quarter
−$8.3MSep ’24$5.4MDec ’24−$6.5MMar ’25$10.8MJun ’25−$7.6MSep ’25−$17.6MDec ’25−$63.3MMar ’26−$17.7MJun ’26
Fiscal years, by the month each ended
LineDec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Revenue$212.2M$234.7M$202.6M$305.4M$427.5M
Gross profit−$16.6M−$26.8M$90.0M$194.4M$298.2M
Operating income−$446.1M−$667.7M−$180.6M−$23.2M−$13.1M
Net income−$245.4M−$549.0M−$175.8M−$52.3M−$21.0M
Operating cash flow−$190.4M−$319.2M−$180.1M−$28.5M$33.3M
Free cash flow−$199.8M−$326.3M−$185.4M−$34.0M$14.3M
Cash$400.6M$123.9M$99.7M$85.2M$105.0M
Debt$11.0M$11.0M$53.2M$53.1M$52.7M
Shares outstanding108.1M11.8M26.0M28.0M29.2M